Stifel Financial's (NYSE:SF) total client assets rose 4% sequentially and 20% from a year ago to $513.9B at Nov. 30, 2024, ...

Barry Bannister, Stifel chief equity strategist, joins 'Squawk on the Street' to discuss why Bannister thinks the market was ...

Stifel analyst Selman Akyol upgraded DT Midstream, Inc. (NYSE:DTM) to Buy from Hold and raised the price target to $106 from ...

Stifel downgraded RxSight (RXST) to Hold from Buy with a price target of $40, down from $65. The firm’s latest deep-dive survey of surgeons leads to believe that the risk from U.S. premium IOL – ...

ST. LOUIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for November 30, 2024 in an effort to provide timely information to investors ...

Stifel upgraded Denali Therapeutics (DNLI) to Buy from Hold with a $37 price target Denali recently aligned with the FDA to ...

Cloudflare stock was rising Tuesday after a Stifel analyst upgraded shares of the cybersecurity company, citing confidence in ...

Micron’s stock plummeted on Thursday following the company’s earnings report and its weaker-than-expected guidance for the ...

As market dynamics evolve, alternative assets like art and collectibles will be promoted but, like all alternative ...

Stifel lowered the firm’s price target on Sage Therapeutics (SAGE) to $6 from $10 and keeps a Hold rating on the shares. 2024 was “a challenging year,” with shares down about 75% following the failure ...

The Stifel Snow Show continues to bring fans unparalleled access to every sport on the FIS World Cup circuit, including ...

Stifel chief investment strategist Barry Bannister believes higher inflation and slower than expected economic growth will ...